Exchange: NASDAQ·Updated 04:04 PM EST

BTMD News

News
all
press releases
biote Corp. (BTMD) Tops Q3 Earnings Estimates
biote Corp. (BTMD) delivered earnings and revenue surprises of +120.00% and -1.50%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
biote Corp. (BTMD) Tops Q3 Earnings Estimates
biote Corp. (BTMD) delivered earnings and revenue surprises of +120.00% and -1.50%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners patients, today announced financial results for the third quarter ended September 30, 2026. While a recent improvement in procedure volume provides early...
Business Wire
biote Corp. (Nasdaq: BTMD) (Biote or the Company), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our Practitioners patients, today announced the Company will provide third quarter financial results on Wednesday, November 4, 2026, after the...
Business Wire
biote Corp. (BTMD) delivered earnings and revenue surprises of -100.00% and -5.71%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners patients, today announced financial results for the second quarter ended June 30, 2026. Over the past year Biote has achieved meaningful progress in...
Business Wire
biote Corp. (Nasdaq: BTMD) (Biote or the Company), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our Practitioners patients, today announced the Company will provide second quarter financial results on Wednesday, August 5, 2026, after the...
Business Wire
(RTTNews) - Biote Corp. (BTMD), a medical practice-building company, on Monday announced the appointment of Komal Bajaj as Chief Medical Officer, effective June 1...
Nasdaq News: Markets
Biote Corp. (NASDAQ: BTMD) (Biote or the Company) today announced the appointment of Komal Bajaj, MD, MS, as Chief Medical Officer, effective June 1, 2026. Dr. Bajaj is a nationally recognized physician executive, board-certified OB/GYN and reproductive geneticist with more than two decades of...
Business Wire
Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners patients, today announced that Bob Peterson, Chief Financial Officer and Chief Business Officer, has been named Interim Chief Executive Officer and...
Business Wire
biote (NASDAQ:BTMD - Get Free Report) posted its earnings results on Wednesday. The company reported $0.06 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by...
MarketBeat

Advertisement|Remove ads.